Cardiovascular effects of melatonin receptor agonists

By Paulis Ludovit   Simko Fedor   Laudon Moshe  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 11, 2012-11 ,pp. : 1661-1678

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of melatonin receptor agonists and antagonists

By Dubocovich M.L.  

Expert Opinion on Emerging Drugs, Vol. 4, Iss. 1, 1999-01 ,pp. : 153-173

Informa Healthcare

Access to resources Recommend Favorite

Melatonin Receptor Agonists: SAR and Applications to the Treatment of Sleep-Wake Disorders

By  

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 11, 2008-07 ,pp. : 954-968

Bentham Science Publishers

Access to resources Recommend Favorite

Characterization of Substituted Phenylpropylamides as Highly Selective Agonists at the Melatonin MT2 Receptor

By  

Current Medicinal Chemistry, Vol. 20, Iss. 2, 2013-01 ,pp. : 289-300

Bentham Science Publishers

Access to resources Recommend Favorite

Novel non-indolic melatonin receptor agonists differentially entrain endogenous melatonin rhythm and increase its amplitude

By Drijfhout W.J.   de Vries J.B.   Homan E.J.   Brons H.F.   Copinga S.   Gruppen G.   Beresford I.J.M.   Hagan R.M.   Grol C.J.   Westerink B.H.C.  

European Journal of Pharmacology, Vol. 382, Iss. 3, 1999-10 ,pp. : 157-166

Elsevier

Access to resources Recommend Favorite